Paper · 40723922
Genetic Diversity in the Suppressyn Gene Sequence: From Polymorphisms to Loss-of-Function Mutations.
Sugimoto J and 4 others. Biomolecules, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genetic Diversity in the Suppressyn Gene Sequence: From Polymorphisms to Loss-of-Function Mutations. Papers, record 40723922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40723922
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Loss of Function Mutation | Major topic |
| Polymorphism, Genetic | Major topic |
| Genetic Variation | Major topic |
| Humans | |
| Female | |
| Pregnancy | |
| Placenta | |
| Trophoblasts |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R01HD094937 | The National Institutes of Health | R01HD094937 | PubMed | NIH RePORTER | |
| JP17K11238 | JSPS KAKENHI | PubMed | PubMed | ||
| JP20K09644 | JSPS KAKENHI | PubMed | PubMed | ||
| JP25462567 | JSPS KAKENHI | PubMed | PubMed | ||
| 1R21A1145071 | The National Institutes of Health | PubMed | PubMed |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,321,927 | Syncytin-1 and glial cells missing a: hypoxia-induced deregulated gene expression along with disordered cell fusion in primary term human trophoblasts. | Gynecol Obstet Invest | 2009 | https://conductscience.org/library/papers/19321927 | PubMed |
| 2 | 35,859,055 | How trophoblasts fuse: an in-depth look into placental syncytiotrophoblast formation. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35859055 | PubMed |
| 3 | 35,357,919 | The complete sequence of a human genome. | Science | 2022 | https://conductscience.org/library/papers/35357919 | PubMed |
| 4 | 39,078,391 | Conserved cysteine residues in Kaposi's sarcoma herpesvirus ORF34 are necessary for viral production and viral pre-initiation complex formation. | J Virol | 2024 | https://conductscience.org/library/papers/39078391 | PubMed |
| 5 | 26,432,243 | Human genomics: The end of the start for population sequencing. | Nature | 2015 | https://conductscience.org/library/papers/26432243 | PubMed |
| 6 | 21,493,955 | Reduced expression of both syncytin 1 and syncytin 2 correlates with severity of preeclampsia. | Reprod Sci | 2011 | https://conductscience.org/library/papers/21493955 | PubMed |
| 7 | 19,795,446 | Beneficial and detrimental effects of human endogenous retroviruses. | Int J Cancer | 2010 | https://conductscience.org/library/papers/19795446 | PubMed |
| 8 | 34,125,187 | Cell dynamics in human villous trophoblast. | Hum Reprod Update | 2021 | https://conductscience.org/library/papers/34125187 | PubMed |
| 9 | 35,954,303 | Endogenous Retroviruses and Placental Evolution, Development, and Diversity. | Cells | 2022 | https://conductscience.org/library/papers/35954303 | PubMed |
| 10 | 18,215,254 | Human endogenous retrovirus-FRD envelope protein (syncytin 2) expression in normal and trisomy 21-affected placenta. | Retrovirology | 2008 | https://conductscience.org/library/papers/18215254 | PubMed |
1 to 10 of 30
See all 30 referencesCited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,352,360 | Beyond Genetic Conservation: The Baton Pass Model of Essential Biological Functions. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352360 | PubMed |
| 41,184,406 | Variations in blood levels of the anti-fusogenic endogenous retroviral protein suppressyn are associated with fetal growth outcome in preeclampsia. | Sci Rep | 2025 | https://conductscience.org/library/papers/41184406 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ERVH48-1 | 90,625 | PubTator's text mining | https://conductscience.org/library/genes/90625 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40723922
GET https://conductscience.org/api/papers/v1/40723922/references?page=2